EP3464285
Aðferð til framleiðslu á N-(5-(3-(7-(3-flúorfenýl)-3H-imídasó[4,5-c]pýridín-2-ýl)-1H-indasól-5-ýl)pýridín-3-ýl)-3-metýlbútanamíði
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
1.6.2017EP published:
21.9.2022EP application number:
17729694.4
EP translation filed:
12.12.2022Grant published:
15.1.2023EPO information:
European Patent Register
Max expiry date:
31.5.2037Expiry date:
31.5.2026Next due date:
30.6.2026
Title in English:
PROCESS FOR PREPARING N-(5-(3-(7-(3-FLUOROPHENYL)-3H-IMIDAZO[4,5-C]PYRIDIN-2-YL)-1H-INDAZOL-5-YL)PYRIDIN-3-YL)-3-METHYLBUTANAMIDELanguage of the patent:
English
Timeline
Today
1.6.2017EP application
21.9.2022EP Publication
12.12.2022Translation submitted
15.1.2023Registration published
31.5.2026Expires
Owner
Name:
BioSplice Therapeutics, Inc.Address:
9360 Towne Centre Drive, San Diego, CA 92121, US
Inventor
Name:
KC, Sunil KumarAddress:
San Diego CA 92127, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201662344170 PDate:
1.6.2016Country:
US
Number:
201662418657 PDate:
7.11.2016Country:
US
Classification
Categories:
C07D 471/04
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 21.6.2023
Expires: 31.5.2024
Payer: Árnason Faktor ehf.
Number: 8
Paid: 6.6.2024
Expires: 31.5.2025
Payer: Árnason Faktor ehf.
Number: 9
Paid: 18.6.2025
Expires: 31.5.2026
Payer: Árnason Faktor ehf.